SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (29577)12/10/1999 9:53:00 PM
From: Henry Niman  Respond to of 32384
 
It's hard to imagine the FDA not approving Targretin. It works on patients who are refractory to other treatments and side effects are manageable and pill form is convenient. I expect Monday's meeting to go fairly smoothly.



To: Arthur Radley who wrote (29577)12/11/1999 9:04:00 AM
From: Henry Niman  Respond to of 32384
 
McCamant was pretty positive about Targretin approval
quote.bloomberg.com



To: Arthur Radley who wrote (29577)12/11/1999 11:14:00 AM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
More positive press today from Reuters
post.messages.yahoo.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News